| Financial Year |
March 31 2023 |
| Monetary Funds |
222,886,838.75 |
| Held-for-trading Financial Assets |
1,489,514.84 |
| Notes Receivable |
146,047,579.61 |
| Accounts Receivable |
663,717,445.54 |
| Advances to Suppliers |
88,989,657.25 |
| Other Receivables |
24,408,742.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
697,252,788.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,808,097.29 |
| Total Current Assets |
1,916,145,784.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
145,307,423.63 |
| Investment Properties |
-- |
| Fixed Assetes |
601,822,577.60 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
94,050,148.08 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
54,207,620.74 |
| Other Non-Current Assets |
766,331.08 |
| Sub-Total of Non-Current Assets |
963,950,760.99 |
| Total Assets |
2,880,096,545.25 |
| Short-Term Loans |
425,313,749.99 |
| Trading Financial liabilities |
-- |
| Notes Payable |
126,799,693.60 |
| Accounts Payable |
356,289,958.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,009,150.62 |
| Taxes Payable |
17,566,653.84 |
| Interest Payable |
-- |
| Dividend Payable |
190,111.62 |
| Other payables |
14,347,212.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
86,165,133.33 |
| Other Current Liabilities |
83,683,098.04 |
| Sub-Total of Current Liabilities |
1,428,846,928.50 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
138,673.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
30,567,454.44 |
| Total Liabilities |
1,459,414,382.94 |
| Paid-In Capital(Or Share Stock) |
354,528,198.00 |
| Capital Surplus |
996,957,126.51 |
| Surplus Reserve |
49,934,131.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-5,194,908.97 |
| Minority Stockholder's Interest |
11,233,927.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,409,448,234.82 |
| Owner's Equity（Stockholder's Equity） |
1,420,682,162.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,880,096,545.25 |
